跳至主要内容
临床试验/IRCT20181228042156N1
IRCT20181228042156N1招募中3 期

Evaluation the protective effect of Ursodeoxycholic Acid on hepatic damage in patients with neurological diseases treated with Sodium Valporat

Zabol University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 18 years(—)
性别
All

入选标准

  • Willing to participate in the study
  • Definite diagnosis of migraine, bipolar disorder, or epilepsy
  • Age of <18 years
  • Not being pregnant or lactating

排除标准

  • Not willing to participate in the study
  • Systemic diseases, acute or chronic hepatic diseases (hepatitis B, C, cirrhosis), diabetes, celiac, hypertension, cardiovascular diseases, pulmonary diseases, renal diseases
  • Age > 18 years old
  • Using hepatotoxic drugs and antibiotics
  • Not taking more than 10% of the administrated Ursodeoxycholic Acid

研究者

相似试验